Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 26 Artikel )

05.06.2019 | Review | Ausgabe 2/2019 Open Access

HER2+ breast cancer treatment and cardiotoxicity: monitoring and management

Guy Jerusalem, Patrizio Lancellotti, Sung-Bae Kim

08.06.2019 | Review | Ausgabe 2/2019

A review of the influence of mammographic density on breast cancer clinical and pathological phenotype

Michael S. Shawky, Cecilia W. Huo, Michael A. Henderson, Andrew Redfern, Kara Britt, Erik W. Thompson

17.06.2019 | Review | Ausgabe 2/2019

Breast leptomeningeal disease: a review of current practices and updates on management

Nicholas B. Figura, Victoria T. Rizk, Avan J. Armaghani, John A. Arrington, Arnold B. Etame, Hyo S. Han, Brian J. Czerniecki, Peter A. Forsyth, Kamran A. Ahmed

18.06.2019 | Review | Ausgabe 2/2019 Open Access

Quality of DCIS information on the internet: a content analysis

Jayden Blackwood, Frances C. Wright, Nicole J. Look Hong, Anna R. Gagliardi

07.06.2019 | Preclinical study | Ausgabe 2/2019

Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78

Debasis Nayak, Archana Katoch, Deepak Sharma, Mir Mohd. Faheem, Souneek Chakraborty, Promod Kumar Sahu, Naveed Anjum Chikan, Hina Amin, Ajai Prakash Gupta, Sumit G. Gandhi, Debaraj Mukherjee, Anindya Goswami

17.06.2019 | Preclinical study | Ausgabe 2/2019

Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway

Sanja B. Turturro, Matthew S. Najor, Timothy Yung, Liam Portt, Christopher S. Malarkey, Abde M. Abukhdeir, Melody A. Cobleigh

20.06.2019 | Preclinical study | Ausgabe 2/2019

Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer

Edoardo Isnaldi, Domenico Ferraioli, Lorenzo Ferrando, Sylvain Brohée, Fabio Ferrando, Piero Fregatti, Davide Bedognetti, Alberto Ballestrero, Gabriele Zoppoli

22.06.2019 | Preclinical study | Ausgabe 2/2019

Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype

Corena V. Grant, Chase M. Carver, Shayne D. Hastings, Karthik Ramachandran, Madesh Muniswamy, April L. Risinger, John A. Beutler, Susan L. Mooberry

24.06.2019 | Preclinical study | Ausgabe 2/2019

Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts

Marnie Newell, Susan Goruk, Vera Mazurak, Lynne Postovit, Catherine J. Field

28.06.2019 | Preclinical study | Ausgabe 2/2019 Open Access

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer

Vladislav Korobeynikov, Michelle Borakove, Yayi Feng, William M. Wuest, Alex B. Koval, Anna S. Nikonova, Ilya Serebriiskii, Jonathan Chernoff, Virginia F. Borges, Erica A. Golemis, Elena Shagisultanova

06.06.2019 | Clinical trial | Ausgabe 2/2019

Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics

Véronique Diéras, Hervé Bonnefoi, Emilio Alba, Ahmad Awada, Bruno Coudert, Xavier Pivot, Joseph Gligorov, Agnes Jager, Stefania Zambelli, Geoffrey J. Lindeman, Eric Charpentier, Gary T. Emmons, Ignacio Garcia-Ribas, Robert Paridaens, Jaap Verweij

06.06.2019 | Clinical trial | Ausgabe 2/2019

Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study

Shruti Bhandari, Phuong Ngo, Blakely Kute, Mounika Mandadi, Whitney A. Pitman, Xiaoyong Wu, Sandy Lloyd, Marie Corliss Brown, Shesh N. Rai, Dharamvir Jain, Elizabeth C. Riley

06.06.2019 | Clinical trial | Ausgabe 2/2019

Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease

Michelle E. Melisko, Michael Assefa, Jimmy Hwang, Amy DeLuca, John W. Park, Hope S. Rugo

07.06.2019 | Clinical trial | Ausgabe 2/2019

Clinical features of pseudocirrhosis in metastatic breast cancer

Caspian Oliai, Michael L. Douek, Caelainn Rhoane, Abhishek Bhutada, Phillip S. Ge, Bruce A. Runyon, Xiaoyan Wang, Sara A. Hurvitz

15.06.2019 | Clinical trial | Ausgabe 2/2019

Preliminary results of computer-aided diagnosis for magnetic resonance imaging of solid breast lesions

Qiujie Yu, Kuan Huang, Ye Zhu, Xiaodan Chen, Wei Meng

19.06.2019 | Clinical trial | Ausgabe 2/2019

Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia

Polly Niravath, Susan G. Hilsenbeck, Tao Wang, Sao Jiralerspong, Julie Nangia, Anne Pavlick, Foluso Ademuyiwa, Ashley Frith, Cynthia Ma, Haeseong Park, Caron Rigden, Rama Suresh, Matthew Ellis, C. Kent Osborne, Mothaffar F. Rimawi

24.06.2019 | Clinical trial | Ausgabe 2/2019

Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score

Laura L. Michel, Laura Sommer, Rosa González Silos, Justo Lorenzo Bermejo, Alexandra von Au, Julia Seitz, André Hennigs, Katharina Smetanay, Michael Golatta, Jörg Heil, Florian Schütz, Christof Sohn, Andreas Schneeweiss, Frederik Marmé

24.06.2019 | Clinical trial | Ausgabe 2/2019 Open Access

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment

Daniel Förnvik, Kristina E. Aaltonen, Yilun Chen, Anthony M. George, Christian Brueffer, Robert Rigo, Niklas Loman, Lao H. Saal, Lisa Rydén

24.06.2019 | Clinical trial | Ausgabe 2/2019

Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort

Fabian Riedel, Jörg Heil, Manuel Feißt, Mahdi Rezai, Mareike Moderow, Christof Sohn, Florian Schütz, Michael Golatta, André Hennigs

24.06.2019 | Clinical trial | Ausgabe 2/2019 Open Access

Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer

Y. Andersson, L. Bergkvist, J. Frisell, J. de Boniface

24.06.2019 | Clinical trial | Ausgabe 2/2019

Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study

Kyuwan Lee, Irene Kang, Wendy J. Mack, Joanne Mortimer, Fred Sattler, George Salem, Janice Lu, Christina M. Dieli-Conwright

05.06.2019 | Epidemiology | Ausgabe 2/2019

Severe acne and risk of breast cancer

John D. Murphy, Dale Sandler, Alexandra J. White, Katie M. O’Brien

05.06.2019 | Epidemiology | Ausgabe 2/2019

Treatment and survival of Asian women diagnosed with breast cancer in New Zealand

Chunhuan Lao, Ross Lawrenson, Melissa Edwards, Ian Campbell

05.06.2019 | Epidemiology | Ausgabe 2/2019

Is core needle biopsy effective at diagnosing male breast lesions?

Yinlong Yang, Shiping Li, Guangyu Liu, Zhiming Shao

20.06.2019 | Epidemiology | Ausgabe 2/2019

Dietary intake from birth through adolescence in relation to risk of benign breast disease in young women

Catherine S. Berkey, Rulla M. Tamimi, Walter C. Willett, Bernard Rosner, Martha Hickey, Adetunji T. Toriola, A. Lindsay Frazier, Graham A. Colditz

28.06.2019 | Epidemiology | Ausgabe 2/2019

Associations between mammographic density and tumor characteristics in Chinese women with breast cancer

Erni Li, Jennifer L. Guida, Yuan Tian, Hyuna Sung, Hela Koka, Mengjie Li, Ariane Chan, Han Zhang, Eric Tang, Changyuan Guo, Joseph Deng, Nan Hu, Ning Lu, Gretchen L. Gierach, Jing Li, Xiaohong R. Yang

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise